Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.

Eun Hye Kim, Hana Park, Kun Ho Lee, SangHoon Ahn, Seung Min Kim, KwangHyub Han

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.

Original languageEnglish
Pages (from-to)82-86
Number of pages5
JournalUnknown Journal
Volume19
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Chronic Hepatitis B
Muscular Diseases
Siblings
Antiviral Agents
Lamivudine
Nucleosides
Hepatitis B virus
Clinical Trials
Safety
telbivudine

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Molecular Biology

Cite this

Kim, Eun Hye ; Park, Hana ; Lee, Kun Ho ; Ahn, SangHoon ; Kim, Seung Min ; Han, KwangHyub. / Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B. In: Unknown Journal. 2013 ; Vol. 19, No. 1. pp. 82-86.
@article{720858cbf01d4923a2ae2350b0183e85,
title = "Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.",
abstract = "Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.",
author = "Kim, {Eun Hye} and Hana Park and Lee, {Kun Ho} and SangHoon Ahn and Kim, {Seung Min} and KwangHyub Han",
year = "2013",
month = "1",
day = "1",
doi = "10.3350/cmh.2013.19.1.82",
language = "English",
volume = "19",
pages = "82--86",
journal = "Review of Economic Dynamics",
issn = "1094-2025",
publisher = "Academic Press Inc.",
number = "1",

}

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B. / Kim, Eun Hye; Park, Hana; Lee, Kun Ho; Ahn, SangHoon; Kim, Seung Min; Han, KwangHyub.

In: Unknown Journal, Vol. 19, No. 1, 01.01.2013, p. 82-86.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.

AU - Kim, Eun Hye

AU - Park, Hana

AU - Lee, Kun Ho

AU - Ahn, SangHoon

AU - Kim, Seung Min

AU - Han, KwangHyub

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.

AB - Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.

UR - http://www.scopus.com/inward/record.url?scp=84886916778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886916778&partnerID=8YFLogxK

U2 - 10.3350/cmh.2013.19.1.82

DO - 10.3350/cmh.2013.19.1.82

M3 - Article

C2 - 23593614

AN - SCOPUS:84886916778

VL - 19

SP - 82

EP - 86

JO - Review of Economic Dynamics

JF - Review of Economic Dynamics

SN - 1094-2025

IS - 1

ER -